Rockhaven Resources (CVE:RK) Shares Down 6.1%

Share on StockTwits

Rockhaven Resources Ltd. (CVE:RK)’s share price fell 6.1% on Friday . The stock traded as low as C$0.16 and last traded at C$0.16, 103,500 shares traded hands during mid-day trading. An increase of 142% from the average session volume of 42,779 shares. The stock had previously closed at C$0.17.

The firm’s 50-day simple moving average is C$0.14 and its 200-day simple moving average is C$0.14. The firm has a market capitalization of $26.27 million and a PE ratio of -85.00.

About Rockhaven Resources (CVE:RK)

Rockhaven Resources Ltd., an exploration stage company, engages in the acquisition, exploration, and evaluation of mineral property interests in Canada. The company primarily explores for precious and base metal deposits. It holds a 100% interest in the Klaza gold-silver property, which consist of 1,478 mineral claims covering an area of 287 square kilometers located in the Dawson Range Gold Belt, Yukon Territory.

Featured Article: What is the Federal Reserve?

Receive News & Ratings for Rockhaven Resources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockhaven Resources and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Orthopediatrics Corp  Receives Consensus Rating of “Buy” from Analysts
Orthopediatrics Corp Receives Consensus Rating of “Buy” from Analysts
Nuvectra Corp  Given Consensus Recommendation of “Hold” by Brokerages
Nuvectra Corp Given Consensus Recommendation of “Hold” by Brokerages
Agenus  Cut to Sell at BidaskClub
Agenus Cut to Sell at BidaskClub
Talend SA  Receives Average Recommendation of “Buy” from Analysts
Talend SA Receives Average Recommendation of “Buy” from Analysts
SCS Group  Stock Rating Reaffirmed by Peel Hunt
SCS Group Stock Rating Reaffirmed by Peel Hunt
Oxford BioMedica  Given “Buy” Rating at Liberum Capital
Oxford BioMedica Given “Buy” Rating at Liberum Capital


© 2006-2020 Ticker Report